⚫️ Unfiltered Truth for the Modern-Day Orthopedic Professional ⚫️ Subscribe $1/day!

What you need to know about the Stryker CEO change.

Stryker has had only three CEOs since 1977, and each one roughly doubled or tripled the company. John Brown built

Centinel to take the Disc Motion bet public

This is a big one for our industry. Centinel Spine will be testing the public markets soon. Below I will

Surgeon > Robot

Here we go again. Robots still don’t beat a good manual joint replacement. The UK just put a number on

The Ortho Scoreboard That Matters

Measuring the right metrics will help your company be successful. Surgeons will tell you they love the implant. Reps will

🔴 Tiger’s Red-Hot Innovator of the Week: Incisionless spine surgery.

Every Monday I share a startup that I really like. I call it the Red-Hot Innovator of the Week. As

[Tiger’s Weekly Intel] – SI-BONE Extends Granite Beyond the Pelvis, Dual Lumbar NTAPs Go Live, Chest Wall Crowds

Quick Summary before the Deep Dive and Tiger’s Takes. Sector Notable Move Key Strategic Implication SI / Compromised Bone SI-BONE

Why do Ortho founders keep choosing the hardest business models ?

Every week I talk with orthopedic founders who are raising money to fight the same three wars at once: inventory,

A Front-Row Seat into 1,000 Orthopedic Startups

Imagine if someone had visibility into all early orthopedic innovation. Even more specifically, if someone had early discussions with startups

The $11B Spine Market Is Not a Commodity. The Average Is.

ORTHOWORLD correctly estimated the worldwide spine market at $11.1 billion in 2025, up 3.3% from $10.8 billion the year before.

You Don’t Need the Whole Market. You Need a Small Circle of True Customers.

Every week I talk with orthopedic founders who are asking the wrong question: How do we get big enough? Big

🔴 Tiger’s Red-Hot Innovator of the Week: Startup brings a single Tissue Bank catalog. Fifteen Minutes. No Warehouse in Between.

Every Monday I share a startup that I really like. I call it the Red-Hot Innovator of the Week. As

[Tiger’s Weekly Intel] – OTA launches Trauma Metal, S+N Clears LANDMARK Knee, Regenerative Capital Prints

Ortho Conferences are still important, not for sales leads, but they tell us who launches. OTA in Nashville put pelvic

Stay out of the middle. Winners can own the edges.

Let me throw out a theory. Orthopedics is getting harder and harder for the small ortho company to gain market

Why Medartis Just Bought a Cadaver Lab — and Why Surgical Training Is How You Scale

Swiss extremity and CMF specialist Medartis Holding AG bought the M.A.R.C. Institute (Miami Anatomical Research Center) in Doral, Florida. The

“An Engineer Is Not an Engineer”

I hear this request all the time. Ortho executives call and say, “I need an Engineer.” That’s the wrong request.

The 6 PE Orthopedic Orphans

I wrote this article to better understand how our orthopedic Orphans ended up in such a no-man’s-land, why they cannot

🔴 Tiger’s Red-Hot Innovator of the Week: Dutch startup plugs the knee treatment gap

Every Monday I share a startup that I really like. I call it the Red-Hot Innovator of the Week. There

[Tiger’s Weekly Intel] – AOFAS launches; Extremity Metal; Spine Posts Receipts; Venture Stays Quiet.

Conference weeks are about what you can put in a tray, not what you can put on a slide. AOFAS

DePuy Synthes: Why a PE Buyout Beats an IPO

J&J announced an 18–24 month plan last October to separate Orthopaedics into a standalone public company under Namal Nawana. That

Q&A – the future of tissue preservation with Miach Ortho CEO, Sept 17 @ 3:00p EST.

Don’t miss this one. Jamal Rushdy, President & CEO of Miach Orthopaedics, joins us to talk about defining the standard

Reach Orthopaedics assets are for Sale – Oct 13 deadline

Disclaimer: I have no financial interest, just trying to help out an ortho startup with an exit. Eight years is

New therapy emerges to solve RA. The Ortho industry should pay attention.

This breakthrough caught my eye. Could have big ramifications to orthopedics in the future. In our industry, the landscape is

The Macro Reason: Why Your Ortho Startup Still Can’t Raise

I have watched orthopedic entrepreneurs beat their heads against the exact same brick wall since May 2022. That was the

🔴 Tiger’s Red-Hot Innovator of the Week: New Open AR Spine Guidance without a Lock-In

Every Monday I share a startup that I really like. I call it the Red-Hot Innovator of the Week. Spine

[Tiger’s Weekly Intel] – Strategics Bought Robots and Cuff Fixation; Specialists Stacked SKUs, Registries, and First Cases.

Consolidation cycles are about survival, not brand theater. What cleared a term sheet or a 510(k) this week had a

Apparently, Some Startups Can Still Fool Capital Allocators

Stack the right buzzwords and you can still raise capital—even twelve years after founding. Every deck needs a villain and

Hire the Smart Outlier Who Doesn’t Fit. That’s the Hire That Saves You.

In orthopedic startups, many founders get hypnotized by the implant, the regenerative platform, the AI planning software, the 510(k) path.

Hospitals Want a Faster Tuesday, Not New Gadgets

Your customer is not shopping for titanium, polyethylene or another console that looks impressive. They are shopping for a faster

Making sense of the Stryker/ZuriMED acquisition – it’s the Needle, not the Suture

Big Ortho rarely acquires early startups with limited commercial success. However, Stryker just acquired ZuriMED Technologies and its FiberLocker system.

Tiger’s Red-Hot Innovator of the Week: Dutch startup brings us a new knee shock absorber

Every Monday I share a startup that I really like. I call it the Red-Hot Innovator of the Week. I

[Tiger’s Weekly Intel] – Strategics bought fixation and robots; startups advanced FIM and software.

This last week the orthopedic market did not roar. It sorted. Stryker agreed to buy Zurich’s ZuriMED and its FiberLocker

New trend –> Enabling-technology startups are struggling.

What’s going on here? Augmedics, Proprio Vision and Think Surgical have all struggled. Augmedics proved its tech with 13,000 cases

Fastest and Slowest in 2026

Most of our industry is still talking about “orthopedics growing mid-single digits.” That average hides the real story. The US

What the Enovis–eCential Deal actually means for the rest of Spine

If you only skimmed the news, you probably walked away with the wrong story. The wrong story is: Spineart lost

New Zombie Company Award Recipient goes to an SI-Fusion Startup

You don’t ever want to work for a Zombie company. It’s a financial death spiral. When I find a new

🔴 Tiger’s Red-Hot Innovator of the Week: Implant companies sell the parts. This startup wants the operating system.

Every Monday I share a startup that I really like. I call it the Red-Hot Innovator of the Week. It’s

[Tiger’s Weekly Intel] – Where the Money Went: Outcomes Software, SI Fixation, ASC Closets

High Level Overview The themes for you this week are: 1/ US ortho funding is hunting closed-loop data, SI fixation,

Making sense of the Globus acquisition of Higgs Boson.

If you have spent any time reading my stuff, you already know my theory: Business Process > Product. Implants still

Capital is now funding the delivery system, not the device.

There is a sea change happening in ortho. (Sorry. It’s a long article – 8 minute read, but its a

Supercharge your career with AI tools – Sales, Marketing, R&D, Reg/Quality, Clinical, Fin, and Ops.

In our industry, AI is no longer speculative tech theater—it is raw leverage. Many ortho professionals today are using AI

Speed: The Overlooked Weapon for Orthopedic Startups

“Lost time is never found again.” — Benjamin Franklin Let’s talk about the ultimate unfair advantage that small Ortho companies

🔴 Tiger’s Red-Hot Innovator of the Week: How a Startup’s Pocket-Sized Wearable Is Ending Spine Fusion’s Compliance Blind Spot

A new startup is targeting a classic orthopedic issue: taking a proven, non-invasive technology (bone growth stimulation) that had gone